Pricing Log in Create free account
Friday 6 November 2026 Export WAY’s income statement to Excel — free account

Waystar Holding Corp.

WAY Healthcare Health Information Services

Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.

Revenue
+21.2%
EPS
−10.2%
Free cash flow
+23.4%
Total debt
+18.4%

Quarter to September 2026, against a year earlier

28.08 0.80 −2.77%
Market cap
$5.6B
P/E
40.9×
Fwd P/E
31.9×
Dividend yield
—
F-score
6/9
Altman Z
2.16
Beneish M
−2.41
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Waystar Holding Corp. (WAY) EBITDA

Alert me on EBITDA

Waystar Holding Corp.'s EBITDA for fiscal 2025 was $392.5M, up 24.9% from $314.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $444.3M. Waystar Holding Corp. ranks 5th of 43 Health Information Services companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $392.5M 24.90%
FY2024 $314.3M (4.47%)
FY2023 $329.0M 16.31%
FY2022 $282.9M —

Quarterly newest first

Period EBITDA Change
Sep 2026 $103.4M (12.49%)
Jun 2026 $118.2M (3.59%)
Mar 2026 $122.6M 22.41%
Dec 2025 $100.1M 6.29%
9 more quarters

EBITDA against peers

Company EBITDA
BTSG BrightSpring Health Services, Inc. compare $690.0M
HQY HealthEquity, Inc. compare $510.0M
WAY Waystar Holding Corp. $444.3M
DOCS Doximity, Inc. compare $218.1M
HNGE Hinge Health Inc. compare $161.2M
PRVA Privia Health Group, Inc. compare $63.8M
HTFL Heartflow, Inc. compare −$72.7M
SDGR Schrodinger, Inc. compare −$127.8M
TEM Tempus AI, Inc. compare −$166.8M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on WAY